Major Cytochrome P450 Enzymes Responsible for Microsomal Aldehyde Oxygenation of 11-Oxo-Δ8-tetrahydrocannabinol and 9-Anthraldehyde in Human Liver

Drug Metabolism and Pharmacokinetics - Tập 17 - Trang 516-521 - 2002
Kazuhito Watanabe1, Tamihide Matsunaga1,2, Toshiyuki Kimura1, Tatsuya Funahashi1, Yoshihiko Funae3, Tohru Ohshima4, Ikuo Yamamoto5
1Faculty of Pharmaceutical Sciences, Hokuriku University, Kanazawa, Japan
2Division of Pharmacy, Shinshu University Hospital, Matsumoto, Japan
3Osaka City University School of Medicine, Osaka, Japan
4Kanazawa University Faculty of Medicine, School of Medicine, Kanazawa, Japan
5Kyushu University of Health and Welfare, Nobeoka, Japan

Tài liệu tham khảo

Esterbauer, 1990, Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal, Method Enzymol., 186, 407, 10.1016/0076-6879(90)86134-H

Benedetti, 1980, Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipid, Biochim. Biophys. Acta, 620, 261, 10.1016/0005-2760(80)90209-X

Benedetti, 1984, Cytotoxic aldehydes originating from the peroxidation of liver microsomal lipid. Identification of 4,5-dihydroxydecenal, Biochim. Biophys. Acta, 792, 172, 10.1016/0005-2760(84)90219-4

Watanabe, 1980, Identification and determination of 11-oxo-Δ8-tetrahydrocannabinol as an intermediate metabolite of Δ8-tetrahydrocannabinol in the mouse brain and liver, J. Pharmacobio-Dyn., 3, 686, 10.1248/bpb1978.3.686

Watanabe, 1980, Comparison in mice of pharmacological effects of Δ8-tetrahydrocannabinol and its metabolites oxidized at 11-position, Eur. J. Pharmacol., 63, 1, 10.1016/0014-2999(80)90110-7

Yamamoto, 1988, Oxygenation mechanism in the oxidation of xenobiotic aldehyde to carboxylic acid by hepatic microsomes, Biochem. Biophys. Res. Commun., 153, 779, 10.1016/S0006-291X(88)81163-X

Watanabe, 1990, Hepatic microsomal oxygenation of aldehydes to carboxylic acids, Biochem. Biophys. Res. Commun., 166, 1308, 10.1016/0006-291X(90)91008-G

Watanabe, 1991, Oxygenation mechanism in conversion of aldehyde to carboxylic acid catalyzed by a cytochrome P450 isozyme, J. Biol. Chem., 266, 2709, 10.1016/S0021-9258(18)49902-4

Watanabe, 1991, Catalytic activity of cytochrome P450 isozymes purified from rat liver in converting 11-oxo-Δ8-tetrahydrocannabinol to Δ8-tetrahydrocannabinol-11-oic acid, Biochem. Pharmacol., 42, 1255, 10.1016/0006-2952(91)90262-4

Matsunaga, 1993, Cytochrome P450 isozymes catalyzing the hepatic microsomal oxidation of 9-anthraldehyde to 9-anthracene carboxylic acid in adult male rats, Biol. Pharm. Bull., 16, 866, 10.1248/bpb.16.866

Watanabe, 1993, A cytochrome P450 isozyme having aldehyde oxygenase activity plays a major role in metabolizing cannabinoids by mouse hepatic microsomes, Biochem. Pharmacol., 46, 405, 10.1016/0006-2952(93)90516-Y

Narimatsu, 1990, Cytochrome P-450 isozymes in metabolic activation of Δ9-tetrahydrocannabinol by rat liver microsomes, Drug Metab. Dispos., 18, 943

Terelius, 1991, Acetaldehyde as a substrate for ethanol-inducible cytochrome P450 (CYP2E1), Biochem. Biophys. Res. Commun., 179, 689, 10.1016/0006-291X(91)91427-E

Roberts, 1992, Role of isozymes of rabbit microsomal cytochrome P-450 in the metabolism of retinoic acid, retinol and retinal, Mol. Pharmacol., 41, 427

Inayama, 1974, The oxidation of Δ1-and Δ6-tetrahydrocannabinol with selenium dioxide, Chem. Pharm. Bull., 22, 1519, 10.1248/cpb.22.1519

Mechoulam, 1973, Δ6-Tetrahydrocannabinol-7-oic acid. A urinary metabolite: isolation and synthesis, Experientia, 29, 1193, 10.1007/BF01935065

Ohlsson, 1979, Synthesis and psychotropic activity of side chain hydroxylated Δ6-tetrahydrocannabinol metabolite, Acta Pharm. Suec., 16, 21

Watanabe, 1995, Involvement of CYP2C in the metabolism of cannabinoids by human hepatic micro-somes from an old woman, Biol Pharm. Bull., 18, 1138, 10.1248/bpb.18.1138

Watanabe, 1991, Fluorometric assay of microsomal aldehyde oxygenase activity: 9-anthralde-hyde as a substrate, Anal. Biochem., 198, 134, 10.1016/0003-2697(91)90517-W

Matsunaga, 2000, CYP3A4 is a major isoform responsible for oxidation of 7-hydroxy-Δ8-tetrahydrocannabinol to 7-oxo-Δ8-tetrahydrocannabinol in human liver microsomes, Drug Metab. Dispos., 28, 1291

Narimatsu, 1990, Inhibition of hepatic microsomal cytochrome P450 by cannabidiol in adult male rats, Chem. Pharm. Bull., 38, 1365, 10.1248/cpb.38.1365

Lowry, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6

Newton, 1995, Cytochrome P450 inhibitors: evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes, Drug Metab. Dispos., 23, 154

Baldwin, 1995, Ketoconazole and sulfaphenazole as the respective selective inhibitors of P4503A and 2C9, Xenobiotica, 25, 261, 10.3109/00498259509061850

Ono, 1996, Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes, Xenobiotica, 26, 681, 10.3109/00498259609046742

Shimada, 1989, Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principle enzyme involved in the bioactivation of aflatoxins in human liver, Proc. Natl. Acad. Sci., 86, 462, 10.1073/pnas.86.2.462

Agurell, 1986, Pharmacokinetics and metabolism of Δ1-tetrahydrocannabinol and other cannabinoids with emphasis on man, Pharmacol. Rev., 38, 21

Yamamoto, 1991, Metabolism of tetrahydrocannabinol, cannabidiol and cannabinol, the major constituents of marihuana in man, Japanese J. Forensic Toxicol., 9, 2

Bornheim, 1992, Human hepatic metabolism of Δ1-tetrahydrocannabinol, Drug Metab. Dispos., 20, 241

Matsunaga, 1996, Microsomal aldehyde oxygenase (MALDO): purification and characterization of cytochrome P450 isozyme responsible for oxidation of 9-anthraldehyde to 9-anthracene carboxylic acid in monkey liver, J. Biochem., 119, 617, 10.1093/oxfordjournals.jbchem.a021287

Thông tin
Thông tin xuất bản

Drug Metabolism and Pharmacokinetics

Tập 17

516-521

Thông tin tác giả